Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Silence Therapeutics Plc - American Depository Share
(NQ:
SLN
)
6.100
-1.030 (-14.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silence Therapeutics Plc - American Depository Share
< Previous
1
2
3
4
5
6
Next >
The Analyst Landscape: 6 Takes On Silence Therapeutics
↗
June 20, 2024
Via
Benzinga
Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(a)
June 20, 2024
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Present at Jefferies Global Healthcare Conference
May 30, 2024
From
Silence Therapeutics plc
Via
Business Wire
What 7 Analyst Ratings Have To Say About Silence Therapeutics
↗
May 17, 2024
Via
Benzinga
Beyond The Numbers: 7 Analysts Discuss Silence Therapeutics Stock
↗
April 22, 2024
Via
Benzinga
What 4 Analyst Ratings Have To Say About Silence Therapeutics
↗
March 13, 2024
Via
Benzinga
SLN Stock Earnings: Silence Therapeutics Reported Results for Q1 2024
↗
May 16, 2024
Silence Therapeutics just reported results for the first quarter of 2024.
Via
InvestorPlace
Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress
May 16, 2024
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference
April 30, 2024
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
April 29, 2024
From
Silence Therapeutics plc
Via
Business Wire
3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024
↗
April 11, 2024
Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.
Via
InvestorPlace
Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
April 08, 2024
From
Silence Therapeutics plc
Via
Business Wire
7 Biotech Stocks Ready to Ride the Sector’s Resurgence
↗
March 18, 2024
With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.
Via
InvestorPlace
These Analysts Boost Their Forecasts On Silence Therapeutics After Full Year 2023 Results
↗
March 14, 2024
Silence Therapeutics Plc (NASDAQ: SLN) reported a loss for 2023 on Wednesday.
Via
Benzinga
What's Going On With Silence Therapeutics Stock Today?
↗
March 13, 2024
Silence Therapeutics reports narrower Q4 loss, data from zerlasiran study, and strengthened cash position. In March 2024, Mallinckrodt notified Silence that they will not pursue further development of...
Via
Benzinga
Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
March 13, 2024
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Announces Positive Topline 36-Week Data from Ongoing Phase 2 Study of Zerlasiran in Patients with High Lipoprotein(a)
March 13, 2024
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Report Fourth Quarter and Full Year 2023 Results on March 13, 2024
February 28, 2024
From
Silence Therapeutics plc
Via
Business Wire
Earnings Scheduled For March 13, 2024
↗
March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Via
Benzinga
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
February 23, 2024
From
Silence Therapeutics plc
Via
Business Wire
Earnings Scheduled For March 12, 2024
↗
March 12, 2024
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.
Via
Benzinga
Silence Therapeutics Announces Oversubscribed $120 Million Private Placement
February 05, 2024
From
Silence Therapeutics plc
Via
Business Wire
Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday
↗
January 31, 2024
U.S. stocks traded mostly lower, with the Nasdaq Composite falling over 200 points on Wednesday.
Via
Benzinga
Topics
Stocks
Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
January 31, 2024
From
Silence Therapeutics plc
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
December 13, 2023
Via
Benzinga
Silence Therapeutics Strengthens Executive Leadership Team with Key Appointments
December 01, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
November 14, 2023
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Present at Jefferies London Healthcare Conference
November 08, 2023
From
Silence Therapeutics plc
Via
Business Wire
Is This A Miracle Drug For 'Sticky Cholesterol'? Analysts Applaud Safety, Efficacy Of Silence Therapeutics' Heart Disease Candidate
↗
November 01, 2023
Earlier today, Silence Therapeutics plc (NASDAQ: SLN) announced topline results from the multiple-dose component of the APOLLO phase 1 study of zerlasiran (formerly SLN360) in 36 adults with baseline...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
November 01, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
